Imatinib drug page Clinical trials

Trials with Imatinib

Every colorectal cancer trial that includes this drug. Those looking for patients come first.

4Trials
1Recruiting
4Countries
112Planned patients

Showing 1–4 of 4

KQB198 in Combination With Imatinib in Participants With Advanced/Metastatic GIST in 1st Line Setting (SynerGIST-1st Line)
Recruiting Phase 2 46 patients NCT07406633

This study will test an experimental drug called KQB198 in combination with imatinib. The goal is to determine if this combination is safe and tolerable and assess how effective the combination is at treating GIST. Imatinib has been approv…

United States Jun 2026 – Oct 2028 Interventional
Combined with: KQB198
Imatinib as Pre-operative Anti-Colon Cancer Targeted Therapy
Finished Phase 2 5 patients NCT02685046

In this proof-of-concept trial the investigators will study the effects of imatinib treatment on the biology of mesenchymal-type colon cancers.

Netherlands Apr 2016 – Sept 2019 Interventional
First-line Therapy of Stage IV Colorectal Cancer
Finished Phase 1 51 patients NCT00784446

Assessment of safety and toxicity, definition of the dose limiting toxicity (DLT) of the combination therapy consisting of Capecitabine, Oxaliplatin, Bevacizumab and Imatinib.

Germany Apr 2008 – Dec 2012 Interventional
Glivec® Plus m-FOLFOX Avastin® in Advanced Colorectal Cancer
Finished Phase 1 10 patients NCT01271166

This is a Phase I, dose finding, multicentre study evaluating the maximal tolerated dose of Glivec® in combination with mFOLFOX-Avastin®. Patients will be enrolled into each dose level in 3 patient cohorts. Additional cohorts will be enrol…

Australia Oct 2007 Interventional

Where the recruiting trials are